Danae Hamouda, Md

This early-phase trial tests a combination of three widely used drugs—metformin, digoxin, and simvastatin—in people with advanced pancreatic cancer or other solid tumors that have not responded to standard treatments. The main goal is to find the safest dose and check for side ef…